Is Wellbutrin (bupropion) safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wellbutrin (Bupropion) Safety During Pregnancy

Wellbutrin (bupropion) should be avoided during pregnancy due to potential cardiovascular risks to the fetus, including left ventricular outflow tract obstruction and ventricular septal defects. 1

FDA Classification and Risk Assessment

Bupropion does not appear in the FDA pregnancy category listings provided in the guidelines, but based on available evidence, it would likely fall into Category C or D, indicating:

  • There is evidence of potential fetal risk
  • The medication should only be used if potential benefits justify the potential risks to the fetus 2

Cardiovascular Concerns

The most significant concern with bupropion use during pregnancy is the potential for cardiovascular malformations:

  • Bupropion has been associated with a small increased risk of specific cardiovascular defects:
    • Left ventricular outflow tract obstruction
    • Ventricular septal defects 1

Pregnancy Outcomes Research

Limited research on bupropion during pregnancy shows:

  • A 2005 prospective comparative study of 136 women exposed to bupropion during the first trimester found:
    • No major malformations among 105 live births
    • Higher rates of spontaneous abortions compared to control groups (p = 0.009) 3
  • This suggests a potential risk for pregnancy loss that should be considered in the risk-benefit analysis

Clinical Decision Algorithm

  1. First-line approach: Consider non-pharmacological interventions for depression during pregnancy

    • Psychotherapy
    • Support groups
    • Lifestyle modifications
  2. If medication is necessary:

    • Consider antidepressants with better established safety profiles during pregnancy
    • SSRIs like sertraline or citalopram may have more safety data available
  3. If bupropion is being considered:

    • Only use if the maternal benefit clearly outweighs potential fetal risks
    • Reserve for cases where:
      • Other treatments have failed
      • The severity of maternal depression poses greater risk than medication
      • Smoking cessation is critical for maternal health

Monitoring Recommendations

If bupropion must be used during pregnancy:

  • Fetal cardiac monitoring with specialized ultrasound
  • Close maternal monitoring for depression symptoms
  • Lowest effective dose should be used
  • Consider gradual discontinuation before delivery to minimize neonatal effects

Important Caveats

  • The quality of evidence regarding antidepressant use in pregnancy is limited by:
    • Reliance on observational studies rather than randomized controlled trials
    • Potential confounding by indication (depression itself may affect pregnancy outcomes)
    • Limited sample sizes in many studies 4
  • Untreated depression during pregnancy carries its own significant risks to both mother and fetus, which must be weighed against medication risks 5

Breastfeeding Considerations

If bupropion is used during breastfeeding:

  • Monitor the infant carefully for adverse effects, particularly neurological symptoms
  • Watch for vomiting, diarrhea, jitteriness, sedation, or seizures
  • Consider timing breastfeeding to avoid peak maternal drug concentrations 1

In conclusion, while bupropion may not be absolutely contraindicated in pregnancy, the potential cardiovascular risks make it a less preferred option compared to other antidepressants with better established safety profiles during pregnancy.

References

Guideline

Medication Safety and Interactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prescribing without evidence - pregnancy.

British journal of clinical pharmacology, 2012

Research

Antidepressant use during pregnancy: the benefit-risk ratio.

American journal of obstetrics and gynecology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.